Ceftaroline: all 35 studies that test it

Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.

• Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary InfectionEnrolling by invitationNCT07228702Phase 1
• Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired PneumoniaRecruitingNCT02735707Phase 3
• Safety, Tolerability and Efficacy of Ceftaroline in Paediatrics With Late-Onset SepsisTerminatedNCT02424734Phase 2Results posted
• Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in ChildrenCompletedNCT02335905Phase 1/2Results posted
• Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections.TerminatedNCT02202135Phase 3Results posted
• Evaluation of Ceftaroline Fosamil Versus a Comparator in Adult Subjects With Community-acquired Bacterial Pneumonia (CABP) With Risk for Methicillin-resistant Staphylococcus AureusCompletedNCT01645735Phase 4Results posted
• Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial PneumoniaCompletedNCT01524302Phase 4Results posted
• Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin InfectionsCompletedNCT01499277Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in AsiaCompletedNCT01371838Phase 3Results posted
• Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure InfectionsCompletedNCT00633152Phase 2Results posted
• Pharmacokinetics of Ceftaroline in Subjects 12 to 17 Years of AgeCompletedNCT00633126Phase 1Results posted
• Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired PneumoniaCompletedNCT00509106Phase 3Results posted
• Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin InfectionsCompletedNCT00424190Phase 3Results posted
• Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin InfectionsCompletedNCT00423657Phase 3Results posted
• Population Pharmacokinetic (PK) Study of Zinforo (Ceftaroline) in Critical Care Patients With Early-onset Pneumonia and Normal or Augmented Renal ClearanceCompletedNCT03025841Phase 1
• Antibiotic Prophylaxis in Open FracturesStatus unknownNCT02937181Phase 4
• Penetration of Ceftaroline Into Cerebrospinal Fluid(CSF)CompletedNCT02806882Phase 1
• IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaBCompletedNCT02660346Phase 4
• Ceftaroline Diffusion Into Cerebrospinal Fluid of ChildrenStatus unknownNCT02600793Phase 1
• Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSACompletedNCT02582203Phase 4
• The Use of Ceftaroline as Surgical Prophylaxis in Surgery With Risk of MRSA InfectionStatus unknownNCT02307006Phase 4
• Ceftaroline in the Treatment of Bone and Joint InfectionsWithdrawnNCT02005068Phase 4
• Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus BacteremiaCompletedNCT01701219Phase 4
• Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Community Acquired Pneumonia (CABP)CompletedNCT01669980Phase 4
• Safety and Efficacy Study of Ceftaroline in Elderly Subjects With Community-Acquired Bacterial PneumoniaWithdrawnNCT01666743Phase 4
• A Study to Assess the Pharmacokinetics of Ceftaroline in End Stage Renal Disease Patients and Matched Healthy SubjectsCompletedNCT01664065Phase 1
• Pharmacokinetics of Ceftaroline in Normal and Obese SubjectsCompletedNCT01648127Phase 1
• Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal ClearanceCompletedNCT01624246Phase 1
• A Study to Assess Safety, Tolerability and Pharmacokinetics of Ceftaroline in Healthy SubjectsCompletedNCT01612507Phase 1
• Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)CompletedNCT01530763Phase 2/3
• Ceftaroline China Pharmacokinetics StudyCompletedNCT01458743Phase 1
• Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin InfectionsCompletedNCT01400867Phase 2/3
• Study of Blood Levels of Ceftaroline Fosamil in Children Who Are Receiving Antibiotic Therapy in the HospitalCompletedNCT01298843Phase 4
• A Single-centre, Randomised, Double-blind, Placebo-controlled, Four Way Crossover Phase I Study to Investigate the Effect on QT/QTc Interval of Ceftazidime NXL104 or Ceftaroline Fosamil NXL104, Compared With Placebo, Using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male VolunteersCompletedNCT01290900Phase 1
• Comparative Study of Coadministered Ceftaroline Fosamil and NXL104 vs. Intravenous Doripenem in Adult Subjects With Complicated Urinary Tract InfectionsCompletedNCT01281462Phase 2

← Ceftaroline overview